Published November 15, 2014 | Version v1
Journal article

Natural Oil-Based Emulsion Containing Allantoin Versus Aqueous Cream for Managing Radiation-Induced Skin Reactions in Patients With Cancer: A Phase 3, Double-Blind, Randomized, Controlled Trial

  • 1. Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove (Australia)
  • 2. School of Nursing, Queensland University of Technology, Kelvin Grove (Australia)
  • 3. Cancer Care Services, Royal Brisbane and Women's Hospital, Herston, Queensland (Australia)
  • 4. National Health and Medical Research Council Centre for Research Excellence in Nursing, Centre for Health Practice Innovation–Griffith Health Institute, Griffith University, Nathan (Australia)
  • 5. Science and Engineering Faculty, Queensland University of Technology, Brisbane (Australia)

Description

Purpose: To investigate the effects of a natural oil-based emulsion containing allantoin versus aqueous cream for preventing and managing radiation-induced skin reactions. Methods and Materials: A total of 174 patients were randomized and participated in the study. Patients received either cream 1 (the natural oil-based emulsion containing allantoin) or cream 2 (aqueous cream). Skin toxicity, pain, itching, and skin-related quality of life scores were collected for up to 4 weeks after radiation treatment. Results: Patients who received cream 1 had a significantly lower average level of Common Terminology Criteria for Adverse Events at week 3 (P<.05) but had statistically higher average levels of skin toxicity at weeks 7, 8, and 9 (all P<.001). Similar results were observed when skin toxicity was analyzed by grades. With regards to pain, patients in the cream 2 group had a significantly higher average level of worst pain (P<.05) and itching (P=.046) compared with the cream 1 group at week 3; however, these differences were not observed at other weeks. In addition, there was a strong trend for cream 2 to reduce the incidence of grade 2 or more skin toxicity in comparison with cream 1 (P=.056). Overall, more participants in the cream 1 group were required to use another topical treatment at weeks 8 (P=.049) and 9 (P=.01). Conclusion: The natural oil-based emulsion containing allantoin seems to have similar effects for managing skin toxicity compared with aqueous cream up to week 5; however, it becomes significantly less effective at later weeks into the radiation treatment and beyond treatment completion (week 6 and beyond). There were no major differences in pain, itching, and skin-related quality of life. In light of these results, clinicians and patients can base their decision on costs and preferences. Overall, aqueous cream seems to be a more preferred option

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ijrobp.2014.06.034

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2014.06.034;
PII
S0360-3016(14)03406-3;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
90
Journal Issue
4
Journal Page Range
p. 756-764
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
46126357
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
ALLANTOIN; COMPARATIVE EVALUATIONS; EMULSIONS; NEOPLASMS; OILS; PAIN; PATIENTS; SKIN; STANDARD OF LIVING; TOXICITY
Descriptors DEC
AZOLES; BODY; COLLOIDS; DISEASES; DISPERSIONS; EVALUATION; HETEROCYCLIC COMPOUNDS; IMIDAZOLES; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANIC OXYGEN COMPOUNDS; ORGANS; OTHER ORGANIC COMPOUNDS; SYMPTOMS

Optional Information

Copyright
Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.